• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED

6.33% ! 8.4¢
Market Cap $100.4M  !

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA 11/09/25 1 409
11/09/25 Last post  DiiDJJ Comments Created with Sketch.  1  Views Created with Sketch.  409 
ALA 05/09/25 2 809
05/09/25 Last post  abitlikeme Comments Created with Sketch.  2  Views Created with Sketch.  809 
ALA
Company Podcast
05/09/25 0 215
05/09/25 Last post  richiec Comments Created with Sketch.  0  Views Created with Sketch.  215 
ALA 05/09/25 14 3.5K
05/09/25 Last post  Megabeast5000 Comments Created with Sketch.  14  Views Created with Sketch.  3.5K 
ALA 03/09/25 0 179
03/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  179 
ALA
CD19 CAR-NK cell therapy achieved CR
28/08/25 7 2.5K
28/08/25 Last post  Megabeast5000 Comments Created with Sketch.  7  Views Created with Sketch.  2.5K 
ALA 25/08/25 0 178
25/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  178 
ALA 25/08/25 0 145
25/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  145 

See All Discussions arrow Created with Sketch.

Timeline

2025 ESG Report
11 Sep 10:54
 
S&P DJI Announces September 2025 Quarterly Rebalance
05 Sep 17:08
 
Notification of Date of 2025 AGM
03 Sep 08:23
 
US Patent to be granted for iNKT Cell Therapy Platform
28 Aug 08:28
 
Notice Under Section 708A
25 Aug 09:58
 
Application for quotation of securities - ALA
25 Aug 09:56
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.4¢
Change
0.005(6.33%)
Mkt cap ! $100.4M
Open High Low Value Volume
7.8¢ 8.4¢ 7.8¢ $97.89K 1.216M

Buyers (Bids)

No. Vol. Price($)
1 100000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 119034 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.